Work

MUC1 Promoter–Driven DTA as a Targeted Therapeutic Strategy against Pancreatic Cancer

Year: 2014

Type: article

Source: Molecular Cancer Research

DOI: 10.1158/1541-7786.mcr-14-0199

Authors: Renee M. Tholey, Shruti Lal, Masaya Jimbo, Richard A. Burkhart, Fernando F. Blanco, Joseph A. Cozzitorto, Josh D. Eisenberg, Wei Jiang, Christine A. Iacobuzio-Donahue, Agnieszka K. Witkiewicz, Melissa Glbert, Charles J. Yeo, Jonathan R. Brody, Janet A. Sawicki, Jordan M. Winter

Institutions: Thomas Jefferson University, Memorial Sloan Kettering Cancer Center, The University of Texas Southwestern Medical Center, Lankenau Institute for Medical Research

Language: English

Topic: Toxin Mechanisms and Immunotoxins

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2106511520

FWCI: 1.37

Cites: 65

Cited by: 19

Related to: 10